NeuPath Health Inc. NPTH.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.71% | 16.39% | 17.75% | 24.57% | 23.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.71% | 16.39% | 17.75% | 24.57% | 23.78% |
| Cost of Revenue | -0.72% | 17.02% | 19.00% | 23.41% | 24.16% |
| Gross Profit | -5.72% | 13.67% | 12.48% | 29.75% | 22.29% |
| SG&A Expenses | -7.29% | 3.08% | 27.54% | 25.72% | 19.81% |
| Depreciation & Amortization | 1.52% | -4.86% | -3.88% | -4.08% | 2.67% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.55% | 14.42% | 19.54% | 22.83% | 22.90% |
| Operating Income | -5.20% | 98.23% | -97.58% | 231.78% | 45.41% |
| Income Before Tax | 65.42% | 352.37% | -165.26% | 109.16% | 13.24% |
| Income Tax Expenses | -684.77% | -29.99% | -219.70% | 126.77% | 121.99% |
| Earnings from Continuing Operations | 390.13% | 221.29% | -86.31% | 71.20% | -6.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.15% | 19.70% | -15.95% | 25.17% | -25.93% |
| Net Income | 516.73% | 179.29% | -67.66% | 62.21% | -13.78% |
| EBIT | -5.20% | 98.23% | -97.58% | 231.78% | 45.41% |
| EBITDA | -2.88% | 39.73% | -52.23% | 43.66% | 27.09% |
| EPS Basic | 518.18% | 180.39% | -67.74% | 61.54% | -13.16% |
| Normalized Basic EPS | -6.56% | 2,200.00% | -733.33% | 183.33% | 90.63% |
| EPS Diluted | 537.50% | 158.57% | -67.74% | 72.60% | -15.79% |
| Normalized Diluted EPS | -10.17% | 2,100.00% | -733.33% | 183.33% | 84.38% |
| Average Basic Shares Outstanding | -0.43% | 0.13% | -0.33% | 0.09% | 0.47% |
| Average Diluted Shares Outstanding | 3.65% | 3.68% | -0.33% | 3.31% | 2.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |